Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Department of Sports Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Calcif Tissue Int. 2019 Jul;105(1):97-106. doi: 10.1007/s00223-019-00549-6. Epub 2019 Apr 16.
A disintegrin and metalloproteinase 12 (ADAM12) is known to be involved in chondrocyte proliferation and maturation; however, the mechanisms are not fully understood. In this study, expression and localization of ADAM12 during chondrocyte differentiation were examined in the mouse growth plate by immunohistochemistry. Adam12 expression during ATDC5 chondrogenic differentiation was examined by real-time PCR and compared with the expression pattern of type X collagen. The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 system was used to generate Adam12-knockout (KO) ATDC5 cells. Adam12-KO and Adam12 overexpressing cells were used for analyses of ADAM12 expression with or without TGF-β1 stimulation. ADAM12 was identified predominantly in chondrocytes of the proliferative zone in mouse growth plates by immunohistochemistry. Adam12 was upregulated prior to Col10a1 during chondrogenic differentiation in wild-type ATDC5 cells. In Adam12-KO ATDC5 cells, following initiation of chondrogenic differentiation, we observed a reduction in Igf-1 expression along with an upregulation of hypertrophy-associated Runx2, Col10a1, and type X collagen protein expressions. In ATDC5 wild-type cells, stimulation with TGF-β1 upregulated the expressions of Adam12 and Igf-1 and downregulated the expression of Runx2. In contrast, in Adam12-KO ATDC5 cells, these TGF-β1-induced changes were suppressed. Adam12 overexpression resulted in an upregulation of Igf-1 and downregulation of Runx2 expression in ATDC5 cells. The findings suggest that ADAM12 has important role in the regulation of chondrocyte differentiation, potentially by regulation of TGF-β1-dependent signaling and that targeting of ADAM12 may have a role in management of abnormal chondrocyte differentiation.
一种解整合素金属蛋白酶 12(ADAM12)已知参与软骨细胞增殖和成熟;然而,其机制尚未完全阐明。在这项研究中,通过免疫组织化学检查了 ADAM12 在小鼠生长板中软骨细胞分化过程中的表达和定位。通过实时 PCR 检查了 ADAM12 在 ATDC5 软骨分化过程中的表达,并与 X 型胶原的表达模式进行了比较。使用成簇规律间隔短回文重复(CRISPR)-Cas9 系统生成 ADAM12 敲除(KO)ATDC5 细胞。使用 ADAM12-KO 和过表达 ADAM12 的细胞分析 TGF-β1 刺激前后 ADAM12 的表达。通过免疫组织化学鉴定 ADAM12 在小鼠生长板增殖区的软骨细胞中表达。在野生型 ATDC5 细胞中,ADAM12 在 Col10a1 之前在软骨分化中上调。在 ADAM12-KO ATDC5 细胞中,在起始软骨分化后,我们观察到 Igf-1 表达减少,同时肥大相关的 Runx2、Col10a1 和 X 型胶原蛋白表达上调。在 ATDC5 野生型细胞中,TGF-β1 刺激上调了 Adam12 和 Igf-1 的表达,并下调了 Runx2 的表达。相反,在 ADAM12-KO ATDC5 细胞中,这些 TGF-β1 诱导的变化被抑制。ADAM12 过表达导致 ATDC5 细胞中 Igf-1 上调和 Runx2 表达下调。研究结果表明,ADAM12 在软骨细胞分化的调节中具有重要作用,可能通过调节 TGF-β1 依赖性信号转导,靶向 ADAM12 可能在异常软骨细胞分化的管理中发挥作用。
J Bone Miner Res. 2005-12
In Vitro Cell Dev Biol Anim. 2016-3
J Bone Miner Res. 2005-9
J Orthop Surg Res. 2025-6-18
Biochem Biophys Rep. 2022-1-24